Join us for this upcoming DirectInject-LC Virtual User Forum, a unique opportunity to connect with industry peers and share insights into the application of advanced technologies in chemical process development. This event will deepen your understanding of how online HPLC analysis enabled by DirectInject-LC is being used to streamline development workflows with real-time reaction monitoring and insight.
Agenda
09:00 – 09:15 Introduction
09:15 – 09:45 Case Study 1 – Rob Cox, AstraZeneca
09:45 – 10:15 Case Study 2 – Kenji Kurita, Genentech
10:15 – 10:25 Break
10:25 – 10:45 DirectInject-LC Update
10:45 – 11:15 Case Study 3 – Tom Malig, Genentech
11:15 – 11:45 Case Study 4 – Andrew Kukor, Takeda
11:45 – 12:00 Q&A and Closing
Robert Cox
Associate Principal Scientist, AstraZeneca
Robert Cox is a physical organic chemist at AstraZeneca. He received his PhD from University of Edinburgh under the supervision of Prof. Guy Lloyd-Jones before taking up a position in the process understanding team at AZ in 2015. Robert’s main interest is in using phys-org chemistry for process understanding but has also branched into data management, DoE, PAT and automation.
Kenji Kurita
Senior Principal Scientist, Genentech
Kenji Kurita graduated with a BS in Chemical Biology from UC Berkeley and completed his PhD at the University of California at Santa Cruz in Natural Products Discovery focusing on integrating multidimensional bioactivity screening with untargeted metabolomics. After a short postdoc at Simon Fraser University, he joined Genentech and now leads the Process Analytical Group.
Thomas Malig
Principal Scientist, Genentech
Andrew Kukor
Automation Scientist, Takeda